Health Care Enforcement Year in Review & 2020 Outlook Webinar
Feb
13
2020
Date: February 13, 2020
Time: 12:30PM - 1:30PM (EST)
Health care fraud enforcement remained robust in 2019. While criminal enforcement actions involving opioids continued as a top enforcement priority, the civil False Claims Act still remains one of the government’s most powerful enforcement tools. In our annual webinar, Mintz’s Health Care Enforcement Defense team will review the key policy developments, settlements, and court decisions from 2019 and assess their likely impact in 2020 and beyond.
Topics will include:
- Statistical analysis of trends in False Claims Act cases
- DOJ’s continued focus on corporate cooperation and prosecuting individuals
- DOJ’s implementation of new policies, including its efforts to control the litigation of declined qui tam cases through dismissal and the issuance of guidance affecting resolution of civil and criminal enforcement actions
- Examination of common defendants and legal theories in health care fraud enforcement actions in 2019 and predictions for the future
- Lessons learned from False Claims Act retaliation cases
Speakers
Karen advises industry clients on regulatory, transactional, operational, and enforcement matters. She has deep experience handling FCA investigations and qui tam litigation for laboratories and diagnostics companies.
Eóin P. Beirne is co-chair of Mintz’s White Collar Defense and Government Investigations group. He guides clients from a wide range of industries through federal and state investigations and enforcement proceedings.
Kevin is a member of the firm's Health Care Enforcement Defense Group and has significant experience representing health care–related entities in a variety of litigation matters, including contract, regulatory, False Claims Act and class action lawsuits. Kevin's health care industry clients have included pharmacies, PBMs, hospitals, clinical laboratories, diagnostic imaging providers, pharmaceutical companies and managed care organizations.